Product Description: Heme Oxygenase-1-IN-1 (compound 2) is a potent heme oxygenase 1 (HO-1) inhibitor, with an IC50 of 0.25 μM. Heme Oxygenase-1-IN-1 can be used for cancer research[1].
Applications: Cancer-programmed cell death
Formula: C13H15BrN2
Citations: J Clin Invest. 2024 Dec 2;134(23):e181044./Mar Drugs. 2025 Mar 12;23(3):123./Cell Death Dis. 2022 Sep 26;13(9):822./Free Radic Biol Med. 2023 Mar 27;202:46-61./Front Oncol. 2021 May 26;11:679816./Front Oncol. 24 September 2021./Nitric Oxide. 8 October 2022.
References: [1]Floresta G, et al. Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis. Bioorg Chem. 2018 Dec;81:334-339./[2]Zeng X, et al. Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)-NF-кB axis. Free Radic Biol Med. 2023 Jun;202:46-61./[3]Wang X, et al. Mitochondrial GRIM-19 deficiency facilitates gastric cancer metastasis through oncogenic ROS-NRF2-HO-1 axis via a NRF2-HO-1 loop. Gastric Cancer. 2021 Jan;24(1):117-132.
CAS Number: 1093058-52-6
Molecular Weight: 279.18
Compound Purity: 99.11
Research Area: Cancer
Solubility: DMSO : 125 mg/mL (ultrasonic)
Target: Reactive Oxygen Species
English
Deutsch
